Archives
When Context Changes the Meaning of a Yield
2026-11-16
A reported protein concentration is not a standalone measure of platform performance. The rabbit pharming study shows how genetic context, animal genotype, reporter identity, and comparator selection determine what a high milk yield can—and cannot—establish.
Why CSN2 Targeting Raises Rabbit Pharming Yield
2026-11-16
A 2025 study reported that placing a tdTomato transgene at the rabbit CSN2 locus produced 15–20 g/L of recombinant protein in milk from two homozygous animals. The result supports a strong locus-and-promoter effect, but its translational meaning remains limited by the reporter construct, small animal cohort, historical rather than matched comparisons, and unresolved questions about protein quality and reproducibility.
Why the CSN2 Locus Raises Rabbit Pharming Yield
2026-11-15
A 2025 study links targeted insertion at the endogenous CSN2 milk-protein locus with substantially higher reported tdTomato concentrations in rabbit milk. The result supports a mechanistic role for native mammary regulatory context, but it remains a reporter-based proof of concept rather than evidence of therapeutic-product quality, general scalability, or universal performance across recombinant proteins.
How Muscarinic Blockade Relaxes Airways
2026-11-14
Tiotropium bromide is described as a muscarinic acetylcholine receptor antagonist whose airway effects can be understood as reduced cholinergic smooth-muscle contraction. The mechanism supports a conceptual link from receptor signaling to bronchodilation, but the documentation does not provide quantitative, model-specific efficacy evidence for the named material.
Targeted CSN2 Integration in Rabbit Milk Pharming
2026-11-13
A proof-of-concept study tested whether placing a reporter gene within the rabbit CSN2 regulatory context could support strong milk-specific expression and stable inheritance. The findings support locus-directed expression as a promising research strategy, while remaining preliminary for therapeutic-protein production.
Why CSN2 Targeting Raises Rabbit Milk Yields
2026-11-13
A 2025 study links targeted insertion at the rabbit CSN2 locus with markedly increased reporter-protein concentration in milk. The key mechanistic distinction is between editing activity, locus-specific expression, gene dosage, and the final milk concentration readout. The findings are promising but remain bounded by the use of a fluorescent reporter, a small number of homozygous animals, and limited direct comparison with conventional lines.
How CSN2 Targeting Raised Rabbit Pharming Yield
2026-11-12
An evidence-focused analysis of how targeted insertion at the rabbit CSN2 locus produced unusually high reporter-protein concentrations, what the study establishes, and where its applicability remains uncertain.
How a CSN2 Knock-In Raised Rabbit Milk Yield
2026-11-12
A 2025 study used targeted insertion at the rabbit CSN2 locus to place a reporter gene under an endogenous milk-protein promoter. The reported 15–20 g/L milk concentration is notable, but its interpretation is limited by the small number of homozygous animals, the use of tdTomato rather than a therapeutic protein, and the absence of a direct matched comparison.
What High-Yield Rabbit Pharming Evidence Shows
2026-11-11
A 2025 study reported 15–20 g/L tdTomato in milk from two homozygous knock-in rabbits, substantially above yields commonly summarized for conventional pharming lines. The result supports a strong locus-and-promoter effect, but historical comparisons, a small number of high-yield animals, and the use of a fluorescent reporter leave major questions about reproducibility and therapeutic-protein performance.
A Milk-Locus Strategy for Rabbit Protein Pharming
2026-11-11
A proof-of-concept study tested whether placing a reporter gene at the rabbit CSN2 locus could support abundant milk expression and stable inheritance. The findings support the biological rationale, while remaining limited to a reporter protein and a small animal set.
What High-Yield Rabbit Pharming Evidence Shows
2026-11-10
A targeted rabbit line produced 15–20 g/L of a recombinant reporter protein in milk, but the result is best interpreted as a proof of concept for locus-directed expression rather than as a general production benchmark.
Why CSN2 Targeting Raises Rabbit Milk Output
2026-11-10
A mechanistic reading of evidence linking endogenous CSN2-locus targeting with high recombinant-protein concentrations in rabbit milk, including what the study establishes, what remains confounded, and how broadly the result can be applied.
What a CSN2 Rabbit Pharming Study Shows
2026-11-09
A 2025 study examined whether targeted placement of a reporter gene under the rabbit CSN2 milk-protein regulatory region could raise recombinant protein output. Its results are striking but preliminary: high milk concentrations were reported in two homozygous animals, while broader questions about cargo-specific performance, product quality, animal physiology and reproducibility remain open.
Why CSN2 Targeting Matters in Rabbit Pharming
2026-11-09
A literature-focused analysis of a 2025 study showing that targeted placement of a reporter transgene under the rabbit CSN2 regulatory context was associated with markedly higher milk concentrations than conventional pharming benchmarks, while emphasizing the study’s small animal number, reporter-based readout, and limits on therapeutic generalization.
A Targeted Route to Higher Rabbit Pharming Yields
2026-11-08
Song and colleagues tested whether placing a reporter gene under the endogenous rabbit CSN2 milk-protein promoter could overcome the variability and low output associated with conventional transgenic pharming. The study reported 15–20 g/L tdTomato in milk from two homozygous rabbits, while also highlighting important limits: the result concerns a reporter protein, a small animal group, and cross-study comparisons rather than a direct therapeutic-protein manufacturing trial.